Statistics

	Views
Efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, on physical function and pain in patients with psoriatic arthritis, including current skin involvement: Results of a phase 3, randomized, controlled trial	64

Select a period of time:

	Views
Efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, on physical function and pain in patients with psoriatic arthritis, including current skin involvement: Results of a phase 3, randomized, controlled trial	16

RUNA digital repository